3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 2
1
Status
Unknown
32
Completed
28
Recruiting
24
Not yet recruiting
7
Active not recruiting
7
Terminated
4
Withdrawn
2
Enrolling by invitation
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Thoracic
1
Gynecologic
1
Conditions
Breast Neoplasms
369
Neoplasms
253
Carcinoma, Non-Small-Cell Lung
224
Prostatic Neoplasms
192
Lung Neoplasms
140
Colorectal Neoplasms
137
Neoplasm Metastasis
132
Pancreatic Neoplasms
131
Leukemia, Myeloid, Acute
126
Multiple Myeloma
122
Lymphoma
114
Carcinoma, Hepatocellular
111
Ovarian Neoplasms
98
Melanoma
97
Recurrence
93
Leukemia
88
Head and Neck Neoplasms
88
Leukemia, Lymphocytic, Chronic, B-Cell
86
Brain Neoplasms
86
Precursor Cell Lymphoblastic Leukemia-Lymphoma
79
Glioblastoma
77
Lymphoma, Non-Hodgkin
73
Squamous Cell Carcinoma of Head and Neck
71
Lymphoma, Follicular
70
Lymphoma, Large B-Cell, Diffuse
66
Colonic Neoplasms
66
Carcinoma, Renal Cell
61
Hematologic Neoplasms
59
Sarcoma
55
Glioma
53
Interventions
Nivolumab
1
Ipilimumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Withdrawn
×
Interventional
×
Lymphatic Metastasis
×
Clear all
NCT05504642
2023-04-18
CERAD-IMMUNE
Universitätsklinikum Köln
Phase 2
Withdrawn
NCT02341170
2019-04-17
HIPPO-S
Universitätsmedizin Mannheim
Phase NA
Withdrawn